Cargando…
Atorvastatin-Induced Necrotizing Myopathy and its Response to Combination Therapy
Atorvastatin is the most commonly used statin medication to decrease cholesterol levels and prevent atherosclerosis. Myopathy is a reported side effect of atorvastatin which can happen even after more than six months after starting the medication. The side effect on the muscle tissue can range from...
Autores principales: | Boppana, Sri Harsha, Syed, Hasan A, Antwi-Amoabeng, Daniel, Reddy, Prahlad, Gullapalli, Nageshwara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920241/ https://www.ncbi.nlm.nih.gov/pubmed/33659112 http://dx.doi.org/10.7759/cureus.12957 |
Ejemplares similares
-
Sociodemographic Predictors of Outcomes in COVID-19: Examining the Impact of Ethnic Disparities in Northern Nevada
por: Antwi-Amoabeng, Daniel, et al.
Publicado: (2021) -
Atorvastatin-Induced Refractory Thrombocytopenia
por: Ghuman, Jasmine, et al.
Publicado: (2021) -
Statin-Induced Immune-Mediated Necrotizing Myopathy: An Increasingly Recognized Inflammatory Myopathy
por: Stroie, Oana P, et al.
Publicado: (2020) -
Statin-Associated Necrotizing Myopathy: A Feared Complication
por: Nguyen, Suong, et al.
Publicado: (2020) -
Drug-Associated Eosinophilic Fasciitis: A Case of Eosinophilic Fasciitis Secondary to Cemiplimab Therapy
por: Boppana, Sri Harsha, et al.
Publicado: (2021)